title: Expression of a truncated form of the human p55 TNF-receptor in bovine aortic endothelial cells renders them resistant to human TNF.
authors.affiliation: Sandoz Center for Immunobiology, Deaconness Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.
authors.forename: C
authors.initials: C
authors.lastname: Ferran
authors.forename: J T
authors.initials: JT
authors.lastname: Cooper
authors.forename: C
authors.initials: C
authors.lastname: Brostjan
authors.forename: D M
authors.initials: DM
authors.lastname: Stroka
authors.forename: M T
authors.initials: MT
authors.lastname: Millan
authors.forename: D J
authors.initials: DJ
authors.lastname: Goodman
authors.forename: F H
authors.initials: FH
authors.lastname: Bach
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis / Q000502:physiology*; D001011:Aorta; D002417:Cattle; D002478:Cells, Cultured; D015870:Gene Expression; D006367:HeLa Cells; D006801:Humans; D016133:Polymerase Chain Reaction; D018124:Receptors, Tumor Necrosis Factor / Q000096:biosynthesis / Q000502:physiology*; D047888:Receptors, Tumor Necrosis Factor, Type I; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D015703:Antigens, CD; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha